Clinical studies with misonidazole (Q40544562)

21 September 2017

Clinical studies with misonidazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

13 June 2022

C. R. Wiltshire

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

13 June 2022

P. Workman

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

13 June 2022

J. V. Watson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

13 June 2022

N. M. Bleehen

series ordinal

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=277246

13 June 2022

publication date

1 June 1978

1 reference

full work available at URL

21 September 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/277246/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/277246/pdf/?tool=EBI

13 June 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

https://europepmc.org/articles/PMC2149437

13 June 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

https://europepmc.org/articles/PMC2149437?pdf=render

13 June 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A277246

The British Journal of Cancer. Supplement

13 June 2022

published in

1 reference

21 September 2017

1 reference

21 September 2017

286-289

1 reference

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

21 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149437

Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149437

Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149437

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149437

Radiosensitizers of hypoxic cells in solid tumors

17 June 2018

1 reference

12 December 2020

Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours

1 reference

12 December 2020

Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations

1 reference

12 December 2020

Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo

1 reference

12 December 2020

Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles

1 reference

12 December 2020

Identifiers

1 reference

21 September 2017

1 reference